1. World Health Organization. Global hepatitis report 2017. Geneva, Switzerland: World Health Organization; 2017.
2. Pokorska-Spiewak M, Kowalik-Mikołajewska B, Aniszewska M, Pluta M, Marczynska M. Is liver biopsy still needed in children with chronic viral hepatitis? World J Gastroenterol 2015;21(42):12141-12149. PMID:
26576098.
3. Temple JL, Cordero P, Li J, Nguyen V, Oben JA. A guide to non-alcoholic fatty liver disease in childhood and adolescence. Int J Mol Sci 2016;17(6):E947. PMID:
27314342.
4. Mansoor S, Collyer E, Alkhouri N. A comprehensive review of noninvasive liver fibrosis tests in pediatric nonalcoholic fatty liver disease. Curr Gastroenterol Rep 2015;17(6):23PMID:
26031832.
5. Valva P, Rios DA, De Matteo E, Preciado MV. Chronic hepatitis C virus infection: serum biomarkers in predicting liver damage. World J Gastroenterol 2016;22(4):1367-1381. PMID:
26819506.
6. Stasi C, Milani S. Non-invasive assessment of liver fibrosis: between prediction/prevention of outcomes and cost-effectiveness. World J Gastroenterol 2016;22(4):1711-1720. PMID:
26819535.
7. Kapogiannis BG, Leister E, Siberry GK, Van Dyke RB, Rudy B, Flynn P, et al. Prevalence of and progression to abnormal noninvasive markers of liver disease (aspartate aminotransferase-to-platelet ratio index and Fibrosis-4) among US HIV-infected youth. AIDS 2016;30(6):889-898. PMID:
26959353.
8. Alkhouri N. Putting it all together: noninvasive diagnosis of fibrosis in nonalcoholic fatty liver disease in adults and children. Clin Liver Dis (Hoboken) 2017;9(6):134-137. PMID:
30992977.
9. Chen Y, Luo Y, Huang W, Hu D, Zheng RQ, Cong SZ, et al. Machine-learning-based classification of real-time tissue elastography for hepatic fibrosis in patients with chronic hepatitis B. Comput Biol Med 2017;89:18-23. PMID:
28779596.
10. Brenner DA. Reversibility of liver fibrosis. Gastroenterol Hepatol (N Y) 2013;9(11):737-739. PMID:
24764791.
11. Breiman L. Random forests. Mach Learn 2001;45(1):5-32.
12. Elrazek A, Amer M, El-Hawary B, Salah A, Bhagavathula AS, Alboraie M, et al. Prediction of HCV vertical transmission: what factors should be optimized using data mining computational analysis. Liver Int 2017;37(4):529-533. PMID:
27125252.
13. Hashem S, Esmat G, Elakel W, Habashy S, Raouf SA, Elhefnawi M, et al. Comparison of machine learning approaches for prediction of advanced liver fibrosis in chronic hepatitis C patients. IEEE/ACM Trans Comput Biol Bioinform 2018;15(3):861-868. PMID:
28391204.
14. Awad A, Mabrouk M, Elakel W, Doss W, Awad T, Kamal S. Statistical and data mining analysis to identify clinical biochemical and pathological features of liver fibrosis versus Metavir score in a cohort of 69,106 chronic, hepatitis C patients in Egypt. Open Forum Infect Dis 2016;3(Suppl_1):432.
15. El Raziky M, Awad AB, Youssef M, Awad A, Elshakawi A, Esmat G, et al. A novel prediction model for liver fibrosis in patients with chronic hepatitis c virus using Fibroscan and routine laboratory data. J Hepatol 2013;58(Suppl 1):S184.
16. Barakat SH, El-Gandy W, Salem M, Ahmed N. Diagnostic algorithm for implementation of non-invasive scores for liver fibrosis in clinical practice in children with chronic hepatitis C. J Hepatol 2015;62(Suppl 2):S507.
17. Barakat S, El-Gendy W, El-Naga HA, Salem M. Validation and comparison of six non-invasive scores for the diagnosis of liver fibrosis in children with chronic hepatitis C. J Hepatol 2014;60(1_Suppl):S312.
18. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22(6):696-699. PMID:
7560864.
19. Barakat NH, Bradley AP, Barakat MN. Intelligible support vector machines for diagnosis of diabetes mellitus. IEEE Trans Inf Technol Biomed 2010;14(4):1114-1120. PMID:
20071261.
20. Ghaffar TA, Youssef A, Zalata K, ElSharkawy A, Mowafy M, Wanis AA, et al. Noninvasive assessment of liver fibrosis in Egyptian children with chronic liver diseases. Curr Pediat Res 2016;20(1-2):57-63.
21. Poynard T, Ratziu V, Benmanov Y, Di Martino V, Bedossa P, Opolon P. Fibrosis in patients with chronic hepatitis C: detection and significance. Semin Liver Dis 2000;20(1):47-55. PMID:
10895431.
22. Jackson JA, Konomi JV, Mendoza MV, Krasinskas A, Jin R, Caltharp S, et al. Performance of fibrosis prediction scores in paediatric non-alcoholic fatty liver disease. J Paediatr Child Health 2018;54(2):172-176. PMID:
28948665.
23. Yang HR, Kim HR, Kim MJ, Ko JS, Seo JK. Noninvasive parameters and hepatic fibrosis scores in children with nonalcoholic fatty liver disease. World J Gastroenterol 2012;18(13):1525-1530. PMID:
22509085.
24. Schmid P, Bregenzer A, Huber M, Rauch A, Jochum W, Mullhaupt B, et al. Progression of liver fibrosis in HIV/HCV co-infection: a comparison between non-invasive assessment methods and liver biopsy. PLoS One 2015;10(9):e0138838. PMID:
26418061.